Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
T. Pascual1, A. Fernandez-Martinez1, M. Tanioka1, M.V. Dieci2, S. Pernas Simon3, J. Gavila Gregori4, V. Guarneri5, J. Cortés6, P. Villagrasa7, M.J. Vidal8, B. Adamo8, M. Muñoz8, G. Griguolo9, A. Llombart Cussac10, A.M. Antunes De Melo e Oliveira11, L. Paré7, L.A. Carey12, C.M. Perou1, A. Prat8
Communication in congress
ePoster
ESMO BREAST
2020
